Europe is a multicultural continent where the consumption of fermented milks has traditionally been high in several countries. Thus, it is no wonder that the market for fermented dairy products with probiotic bacteria has been successful. The market for food applications of probiotics is clearly larger than that for probiotics sold in capsules, sachets, and other pharmaceutical forms. Yogurt-type drinks are the fastest-growing product category, but the diversity of probiotic food applications is not limited to milk-based products. Probiotic fruit juices, berry soups, and soy-and cereal-based fermented products are also sold. Some probiotic strains that are successful in Europe are marketed globally, but there is also a variety of local probiotic strains that are key players in their limited markets. The health messages of probiotic products have focused mainly on general well-being and support of gastrointestinal microbiota. However, because of newly accepted regulation from the European Union regarding health claims, such claims will be evaluated officially, which may substantially change their content. However, more-specific product claims may also appear on the market. This article describes trends and phenomena in mainly the food sector, which covers the most-successful probiotic applications, but food supplements are also discussed.
Europe is a continent of 140 countries, representing different cultures and languages. Thus, it is difficult to provide a comprehensive description of the European market for probiotics. European legislation is not harmonized; probiotics are regulated under both common directives and national regulations. Probiotic foods and food supplements are covered by the Food Products Directive and Regulation (regulation 178/2002/EC; directive 2000/13/EU). Some probiotic products have been traditionally marketed as herbal products. However, the Herbal Medicinal Products Directive (2004/ 24/EC) states that all current microbial products marketed in the herbal medicinal product category need to apply for and obtain a drug registration, or they will be transferred to the category of food supplements.
Finally, registered drugs are covered under the Drug Law (65/65/EC, amended).
Nutrition and health claims fall under a new European Union regulation (1924/2006 ) that categorizes health claims into 3 categories: (1) other health claims (article 13), which include claims that either are based on generally accepted scientific evidence understood by the average consumer or are based on newly developed scientific data; (2) claims of reduction of disease risk (article 14); and (3) all claims concerning the development and health of children (articles 13 and 14). The European Commission establishes the communities' registers of claims. In the future, only accepted claims can be used. The European Food Safety Authority evaluates all claims. It is currently unclear whether any claims about probiotics will be "generally accepted" (article 13) or whether all accepted claims must be strain specific.
Europeans consume probiotics in foods and in food (dietary) supplements. The consumer market for probiotic foods is 11.4 billion euros in western Europe [1] . The biggest sector is yogurt and desserts, with sales of ∼1 billion euros, and the rest of the market is primarily probiotic milks. Annual growth of sales is forecasted at ∼7%-8% over the next 5 years. The food supplement business is estimated at 10% of the total market for probiotics.
Not only do Europeans not fear eating bacteria, they also associate lactic acid bacteria with "gut health." Traditional use and wide acceptance are, therefore, key factors in the success of this market. Probiotic foods are sold in grocery stores and supermarkets, whereas food supplements are available mainly in pharmacies and health food shops. Probiotics are added to both fresh and fermented dairy products (e.g., milk, fermented milk, and yogurt). The packages are traditional single or multipack cups or tubs, rather than larger sizes. Yogurt eaten with a spoon is made with probiotic bacteria in the fermentation process, together with a yogurt culture. This market is estimated at ∼1 billion euros.
The most popular format, however, is the "daily-dose" drink (i.e., a single serving of 65-125 mL, which is supposed to contain an effective dose of bacteria), which was introduced to Europe in 1994 by the Japanese company Yakult, when it established a production plant in The Netherlands. Me-too products followed. Today's market leaders include Danone (Actimel [DanActive in the United States]) and Yakult (both of which use a strain of Lactobacillus casei), with a combined market value of 1.2 billion euros (in 2003) [2] . The differences between the US and European markets for probiotics may be easily explained by the annual per-capita consumption of fermented milk products (including yogurt) in Europe (35-45 L/person/ year), particularly in Scandinavian countries and The Netherlands, which is considerably higher than that in North America (4-5 L/person/year) (figure 1).
Probiotic foods are manufactured by adding the probiotic strains simultaneously with the standard cultures in the fermentation tank. In an alternative process, fermentation takes place separately, and probiotic cultures (e.g., Lactobacillus acidophilus and Bifidobacterium species) are combined to form the final product. Mesophilic Lactococcus/Leuconostoc cultures are used in Scandinavian countries, The Netherlands, and eastern Europe [5] in fermented milk drinks. In Finland, the most popular probiotic dairy product is traditional fermented milk supplemented with Lactobacillus rhamnosus strain GG, which comprises 150% of all Finnish products containing L. rhamnosus GG, and, compared with other nations globally, Finland has the highest annual consumption of probiotics (6 L/person/ year).
Daily-dose drinks are fermented milks or yogurt drinks flavored with juice or juice concentrates. Cultures include those from traditional yogurt together with у1 probiotic strain. Although not widely publicized, the storage stability of daily-dose products is thought to be good, and they also contain wellknown probiotic strains. Other active ingredients-such as prebiotics, plant sterols, or stanol esters for lowering levels of serum cholesterol, and antioxidative substances-are often added.
Nonfermented probiotic milks also exist in Europe, although they do not have long histories of traditional use. Many are available only regionally, with moderate success in the market. A Scandinavia-specific concept is the introduction of probiotic juices and berry soups, but sales will probably grow elsewhere as well. The addition of probiotics to juices may require special technology, but the combinations of probiotic strains with the fruity taste and healthy image of juices have been very successful.
The effect of the food matrix on probiotic viability is important. Having a good buffering capacity, milk is a good carrier for probiotic strains [6] . Furthermore, refrigeration of probiotic foods guarantees good storage stability for probiotic strains, compared with dry products that have long shelf lives. Despite refrigeration, some products have poor strain survival [7] . In central Europe, so-called bio yogurts are preferred more for their mild taste than for the health benefits. Recently, however, these products have received criticism because of poor viability of strains; this will jeopardize the ability of manufacturers to make health claims about these products or to assert that they contain probiotics. Probiotic niche products include ice cream, cheese, candy, and chewing gum, although they do not play a major role in the European marketplace. Sometimes, probiotics are combined with soy and oat and then are added to cow milk-based probiotic products. Alternatively, entirely oat-or soy-based material is fermented with probiotics and other cultures. A fairly new and potentially bigger product category includes breastmilk substitutes, milks for older babies (i.e., "follow-on" milks), and special infant formulas. Legislation for infant formulas is extremely strict, and strains used in such products must be well documented.
The most common species of probiotics used in foods are lactobacilli and bifidobacteria (table 1) . Imaginary names are also used on package labels and in marketing, such as Bifidobacterium digestivum, Digestivum essensis, and Lactobacillus anti-caries. It will be interesting to learn the attitude of European Union authorities toward these names.
The same lactobacilli and bifidobacteria are used in both foods and food supplements. In addition, Enterococcus species, Bacillus species, Escherichia coli, Saccharomyces boulardii (a yeast), and other species are used in food supplements (table  2) . A wider variety of probiotic strains, either singly or in combination, is used in supplements than in foods. Several product formulations exist: hard gelatin or vegetable capsules, tablets with or without enterocoating (e.g., those that dissolve in neutral conditions), chewable tablets, and sachets. Supplement formulations may also contain other active components, including vitamins and prebiotics. Probiotics are also sold in oil suspensions, which makes them easy to administer to infants. Furthermore, probiotics are combined with oral rehydration salts for the treatment of acute diarrhea. The salts and the probiotic strain can be packed in separate sachets, or the salt solution can be put in a carton and the bacteria in a straw (i.e., suspended in oil and dried inside the straw). At least some of these products are registered as drugs.
Estimates of market size are difficult to make, especially for products with documented health effects. Although hundreds of products are marketed and labeled as probiotics, many of the strains they contain have not been evaluated in scientific trials involving humans. Also, strain identification is not always clear, and the viable counts are not mentioned on the package labels. However, is dose information important for general consumers? Do they understand what it means? A higher dose does not always mean a better effect, and more strains do not necessarily mean a more effective product. Health claims that are being considered for approval should be connected to an effective daily intake, preferably to a serving size and a recommended frequency of consumption.
This article does not deal with any health or functional claims used in the marketing of probiotics in Europe, as no harmonized approval system for such claims existed before 2007. Regulations in only a few countries have made it possible to get an official approval of health claims-for example, in Sweden, the United Kingdom, and The Netherlands. With the acceptance of the new regulation from the European Union, the use of unauthorized claims and promises will be impossible. This may also lead to a swift move from general claims about health benefits and intestinal health to more-precise claims and products targeted to more-specific areas of health. Research is focused on mechanistic studies, as the role of intestinal microbiota in health and disease is becoming better understood. Although the trend is to combine probiotic strains to get an improved product, it is important to gain an understanding of the effects of individual strains, including potential antagonistic interactions between strains. Certainly, the medical use of probiotics will continue to increase, and more probiotic products will be registered as drugs. In particular, genetically modified bacteria will find their way into drugs, and manufacturing plants that specialize in production of both drugs and genetically modified organisms will need to be established.
